This site is intended for Healthcare Professionals only.

McKesson UK’s CEO Toby Anderson steps down with immediate effect

Date:

Share post:

McKesson UK‘s CEO Toby Anderson has stepped down from the role with immediate effect after over three years with the company.

Toby joined McKesson UK as CEO in September 2018 moving from health & beauty retailer A.S. Watson Group, where he spent 12 years in various roles. As CEO Asia and Eastern Europe, Toby was responsible for a rapidly growing business with more than 3,300 stores – including 1,500 pharmacies.

Prior to that Toby spent 11 years in a number of senior roles with J. Sainsbury, the second largest grocery retailer in the UK, his last role being Head of Online.

Dominik Meüser from AURELIUS Group said: “We are extremely grateful for the commitment Toby has demonstrated over the years to help us achieve the McKesson vision of becoming the UK’s leading healthcare organization. His leadership, during a period of great uncertainty, has given us the solid foundations we can now build on to deliver sustained success in the future.

“As well as helping to turnaround the profitability of our business, Toby also oversaw our inspirational response to the Covid-19 pandemic, where we ensured that our customers and patients could continue to receive the vital medicines and services they needed.

“We remain focused on delivering great services for our customers and patients across our individual businesses. Through our core businesses – LloydsPharmacy, LloydsPharmacy Clinical Homecare, and AAH – we play a vital role in protecting the health of communities across the country and we have an exciting opportunity to grow and improve our businesses even more over the next few years.”

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

50% of NHS hospital trusts could be using EPS by 2026

EPS was introduced at six NHS hospital trusts in England in November 2023, following a pilot service conducted...

UK launches new 5-year national plan to combat antimicrobial resistance

The plan outlines ambitious targets to drive down inappropriate use of antimicrobials and stimulate further development of new...

Pharmacy bodies unite to enhance workforce wellbeing

The RPS/PS workforce wellbeing survey 2023 revealed that most pharmacists continue to operate under challenging conditions, with elevated...

Northern Ireland releases plan to fully realise the potential of community pharmacies

NI Community Pharmacy Strategic Plan 2030 envisions an expansion of clinical services offered by community pharmacies The Department...